Display Settings:

Format

Send to:

Choose Destination
We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
    Clin Infect Dis. 2003 Jan 1;36(1):97-100. Epub 2002 Dec 11.

    Hepatitis C virus and human immunodeficiency virus coinfection in an urban population: low eligibility for interferon treatment.

    Source

    Boston Medical Center, Boston University School of Medicine, Boston, Massachusetts 02118, USA. catherine.fleming@bmc.org

    Abstract

    One hundred eighty human immunodeficiency virus (HIV)- and hepatitis C virus (HCV)-coinfected patients were prospectively evaluated for suitability for interferon and ribavirin therapy. Of the 149 patients with chronic HCV infection who completed the evaluation, 44 (30%) were eligible for treatment and 105 (70%) were ineligible, with the main barriers being missed clinic visits, active psychiatric illness, active drug or alcohol use, decompensated liver disease, or medical illness.

    PMID:
    12491208
    [PubMed - indexed for MEDLINE]
    Free full text

      Supplemental Content

      Icon for HighWire

      Save items

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk